SEC Tracker
Get the app

Gilead Sciences GILD

Gilead Sciences (GILD) reports sales.

Daniel Patrick O'Day, insider filing for GILD

Form
4
Filed
Importance
Routine
  1. Oct 1, 2026 - Sold 12,000 shares at $147.719
  2. Oct 1, 2026 - Sold 3,000 shares at $148.6265
  3. Reported under a Rule 10b5-1 trading plan

Written from the Form 4 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Gilead Sciences files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2836) and public float over $2B, nearest public float first, as each company reports it on its annual report cover.

  1. Amgen AMGN public float $150.1B, Jun 30, 2025
  2. Biogen BIIB public float $18.4B, Jun 30, 2025
  3. Moderna MRNA public float $9.9B, Jun 30, 2025
  4. Neurocrine Biosciences NBIX public float $9.5B, Jun 30, 2025
  5. Exelixis EXEL public float $9.4B, Jul 4, 2025